↓ Skip to main content

Risperidone versus other atypical antipsychotics for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Readers on

mendeley
132 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risperidone versus other atypical antipsychotics for schizophrenia
Published in
Cochrane database of systematic reviews, January 2011
DOI 10.1002/14651858.cd006626.pub2
Pubmed ID
Authors

Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S, Katja Komossa, Christine Rummel-Kluge, Sandra Schwarz, Franziska Schmid, Heike Hunger, Werner Kissling, Stefan Leucht

Abstract

In many countries of the industrialised world second-generation ("atypical") antipsychotics (SGAs) have become the first line drug treatment for people with schizophrenia. The question as to whether and if so how much the effects of the various SGAs differ is a matter of debate. In this review we examined how the efficacy and tolerability of risperidone differs from that of other SGAs.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 2%
Chile 1 <1%
Brazil 1 <1%
United States 1 <1%
Uruguay 1 <1%
Canada 1 <1%
Unknown 125 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 28 21%
Student > Master 22 17%
Student > Ph. D. Student 16 12%
Student > Postgraduate 15 11%
Student > Bachelor 13 10%
Other 38 29%
Readers by discipline Count As %
Medicine and Dentistry 66 50%
Psychology 16 12%
Nursing and Health Professions 9 7%
Unspecified 9 7%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Other 24 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2017.
All research outputs
#1,687,364
of 11,469,117 outputs
Outputs from Cochrane database of systematic reviews
#4,437
of 9,120 outputs
Outputs of similar age
#44,721
of 252,933 outputs
Outputs of similar age from Cochrane database of systematic reviews
#123
of 237 outputs
Altmetric has tracked 11,469,117 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,120 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.7. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 252,933 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 237 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.